Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-08

Clinical Trial Update: Surveillance of Suspected Dengue Cases for Access to Care for Subjects Identified as Seronegative or Undetermined Before Receiving CYD Dengue Vaccine in Previous Clinical Studies in Colombia

View source ↗

Summary

An ongoing surveillance update in Colombia assessing suspected dengue cases to ensure access to care for participants who were seronegative or had undetermined …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYD Dengue vaccine (dengue vaccine, live attenuated tetravalent)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Dengue Fever | Status: ACTIVE_NOT_RECRUITING